Censo Biotechnologies

CRO offering drug discovery and toxicity testing services via induced pluripotent stem cell (iPSC) technology

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2016 groups23 employees language censobio.com

Social engagement

Social engagement: 2.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Bank & private debt133%
Other / undisclosed133%

Recent activity

30 Jun 2026
Event
From 2D Cardiomyocytes to 3D functional insights webinar
30 Jun 2026
Event
webinar exploring how to bridge the gap between traditional 2D cardiomyocyte models and more predictive 3D functional assays
26 Jun 2026
Recognition
Coming soon